methamphetamine has been researched along with Drug Withdrawal Symptoms in 201 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (7.46) | 18.7374 |
| 1990's | 8 (3.98) | 18.2507 |
| 2000's | 57 (28.36) | 29.6817 |
| 2010's | 94 (46.77) | 24.3611 |
| 2020's | 27 (13.43) | 2.80 |
| Authors | Studies |
|---|---|
| Mancino, MJ; McGaugh, J; Oliveto, A; Thompson, RG; Thostenson, JD; Wilson, MP | 1 |
| Ciccarone, D; Shoptaw, S | 1 |
| Kalayasiri, R; Krusong, K; Maes, M; Rungnirundorn, T | 1 |
| Han, Y; Li, P; Liu, YL; Sun, YZ; Yang, XG; Zhao, XT; Zhou, C | 1 |
| Chen, C; Chen, F; Chen, M; Ma, Y; Peng, Q; Wang, H; Wang, K; Wu, H; Xie, Z; Yang, J; Yu, J; Zhang, Y; Zhang, Z; Zhou, Y | 1 |
| Jia, J; Kong, D; Kuang, YQ; Li, Y; Lu, D; Peng, QY; Re, GF; Wang, KH; Xie, ZR; Xu, Y; Yu, J; Zhang, Z | 1 |
| Bai, L; Chen, F; Chen, M; Du, Y; Duan, Y; Gao, J; Kuang, YQ; Ma, Y; Peng, Q; Shi, K; Tian, W; Wang, H; Wang, K; Wu, H; Xie, Z; Xiong, P; Xu, Y; Yang, J; Yu, J; Zhang, Y; Zhang, Z; Zhou, Y; Zhu, M; Zhu, T | 1 |
| Arabiyan, A; Ghavimi, H; Hosseini, MJ; Mobassem, S | 1 |
| Acheson, LS; Ezard, N; Farrell, M; McKetin, R; Siefried, KJ; Williams, BH | 1 |
| Acheson, LS; Brett, J; Christmass, M; Dunlop, A; Ezard, N; Farrell, M; Gill, A; Lintzeris, N; McKetin, R; Rodgers, C; Shoptaw, S; Siefried, KJ | 2 |
| Li, MJ; Shoptaw, SJ | 1 |
| Fan, Y; Ge, F; Guan, X; He, T; Li, N; Lu, X; Wang, Z; Wen, J; Xu, B; Xu, X; Yang, P | 1 |
| He, L; Liu, F; Liu, TQ; Ma, YJ; Wen, L; Yang, BZ; Zhang, XJ | 1 |
| Du, D; Fan, Y; Ge, F; Guan, X; Lu, X; Pan, W; Peng, Y; Song, H; Xu, X; Yang, X | 1 |
| Chetsawang, B; Cornish, JL; Na Nakorn, P; Ngampramuan, S; Panmanee, J; Pannengpetch, S; Polvat, T; Prasertporn, T; Suwanjang, W | 1 |
| Jang, WJ; Jeong, CH; Kim, S; Lee, S; Ryu, IS; Yu, H | 1 |
| Campbell, SC; Garfield, JBB; Lubman, DI; Lum, JAG; Manning, V; Mroz, K; Piercy, H; Staiger, PK; Verdejo-Garcia, A | 1 |
| Brannock, C; Cadet, JL; Daiwile, AP; Jayanthi, S; Ladenheim, B; McCoy, MT; Schroeder, J | 1 |
| Hager, L; Kamp, F; Koller, G; Krause, D; Manz, K; Neumann, S; Proebstl, L; Riebschläger, M; Schacht-Jablonowsky, M; Schreiber, A; Soyka, M; Straif, M | 1 |
| Feng, L; He, J; He, W; Lin, S; Qiu, H; Ren, W; Ruan, Y; Yuan, C | 1 |
| Chen, PY; Huang, MC; Kao, CF; Lee, WC | 1 |
| Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR | 1 |
| Altshuler, RD; Li, X; Lin, H | 1 |
| Hao, W; Liao, Y; Liu, J; Liu, T; Qi, C; Tang, J; Tang, YY; Wang, X; Wu, Q; Xie, A; Yang, WFZ | 1 |
| Bluthenthal, RN; Ceasar, RC; Kirkpatrick, M; Kral, AH; Simpson, KA; Wenger, LD; Zhao, J | 1 |
| Bonomo, Y; Campbell, EJ; Collins, L; Galettis, P; Johnstone, J; Lawrence, AJ; Norman, A; Pastor, A | 1 |
| Gong, Q; Huang, X; Jiang, P; Kendrick, K; Li, J; Li, L; Lu, L; Sun, J; Zhou, X | 1 |
| Bayani Ershadi, AS; Dastvar, S; Ghavimi, H; Hosseini, MJ | 1 |
| Daniulaityte, R; Getz, K; Silverstein, SM; Zule, W | 1 |
| Cao, Y; Deng, H; Li, Z; Liu, K; Qi, Y; Song, C; Zhang, H | 1 |
| He, J; Ren, W; Su, H; Tao, J; Xie, Y; Zhang, J; Zhang, X | 1 |
| Bugarin, A; Gerson, J; Hart, EE; Izquierdo, A; Jentsch, JD; Stolyarova, A; Thompson, AB | 1 |
| Ahmadi, J; Razeghian Jahromi, L | 1 |
| Cai, Y; Feng, L; Gu, Y; Gutteea, P; He, J; Luan, X; Lv, D; Ren, W; Su, H; Tao, J; Wu, C; Xie, Y; Zhang, J; Zhao, J | 1 |
| Akhondzadeh, S; Moazen-Zadeh, E; Morabbi, MJ; Razaghi, E; Safi-Aghdam, H; Vousoghi, N; Zarrindast, MR | 1 |
| García-Cabrerizo, R; García-Fuster, MJ | 1 |
| Bossert, JM; Carreria, MB; Cowan, CW; Harvey, BK; Li, X; Lofaro, OM; Nestler, EJ; Richie, CT; Shaham, Y; Son, H; Surjono, F; Witonsky, KR; Zeric, T; Zhang, J | 1 |
| Baxter, E; Conway, J; Usher, K; Woods, C | 1 |
| Beste, C; Rädle, M; Stock, AK | 1 |
| Gerson, JO; Hart, EE; Izquierdo, A | 1 |
| Abiero, A; Botanas, CJ; Cheong, JH; Custodio, RJ; de la Peña, JB; Kim, HJ; Kim, M; Ryoo, ZY; Sayson, LV | 1 |
| Hou, W; Tao, Y; Yu, L; Zeng, L; Zong, L | 1 |
| Liang, Y; Wang, L; Yuan, TF | 1 |
| Chen, H; Gu, Y; He, J; Luan, X; Lv, D; Qiu, H; Ren, W; Shen, H; Su, H; Zhang, J; Zhao, K | 1 |
| Ghimire, B; Hellmuth, L; Houlton, SK; Mojica, E; Phillips, TJ; Schmidt, B; Shabani, S | 1 |
| Chen, L; Li, C; Li, Y; Ru, Q; Tian, X; Xiao, H; Xiong, Q; Zhou, M | 1 |
| Bernstein, I; Greer, TL; Northrup, TF; Tillitski, J; Trivedi, MH; Walker, R | 1 |
| Cadet, JL; Jayanthi, S; Patel, R | 1 |
| Cheng, M; Hao, Y; Jiao, S; Jing, P; Liu, Q; Ma, L; Pan, C; Wang, Y; Wu, Y | 1 |
| Brooks, ML; Jacobskind, JS; Rosinger, ZJ; Zuloaga, DG | 1 |
| Caccamise, AJ; Dolubizno, H; Foster Olive, M; Funke, JR; Loweth, JA; Milovanovic, M; Murray, CH; Stefanik, MT; Wolf, ME | 1 |
| Aguilar, MA; Calpe-López, C; García-Pardo, MP | 1 |
| Ahmadi, J; Biuseh, M; Sahraian, A | 1 |
| Cimbro, R; Davis, IR; Li, X; Lofaro, OM; Rubio, FJ; Zhang, J | 1 |
| Chaki, S; Iijima, M; Koike, H | 1 |
| Karila, L; Lejoyeux, M; Petit, A; Sananes, M | 1 |
| Herrold, AA; Napier, TC; Persons, AL | 1 |
| Kawaguchi, M; Okubo, M; Shinomiya, T; Yoshikawa, M | 1 |
| Cornett, EM; Goeders, NE; Guerin, GF; Keller, CM | 1 |
| Belcher, AM; Chefer, S; Schindler, CW; Stein, EA; Vaupel, DB; Yang, S; Yang, Y | 1 |
| Mohammad, A; Ramroop, J; Shen, H; Smith, SS | 1 |
| Bao, Y; Lian, Z; Liu, Z; Yan, S; Zhang, H | 1 |
| Buell, MR; Geyer, MA; Henry, BL; Minassian, A; Perry, W; Young, JW | 1 |
| Correll, CU; Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Downey, LA; Loftis, JM | 1 |
| Bisagno, V; Cadet, JL; García-Rill, E; González, B; Raineri, M; Urbano, FJ | 1 |
| Chen, YL; Liang, Y; Xu, B; Zhang, XC; Zong, L | 1 |
| Guo, J; Han, B; He, J; He, R; Li, L; Liang, H; Lu, Y; Su, H; Sun, H; Sun, Y; Tao, J; Wei, Y; Xie, Y; Zhang, J; Zhang, XY | 1 |
| Bigdeli, I; Hajheidari, S; Miladi-Gorji, H | 2 |
| Bossert, JM; Kambhampati, S; Li, X; Shaham, Y; Zeric, T | 1 |
| Al-Hassani, HK; Gregg, RA; Grizzanti, D; Haidery, M; Raffa, RB; Ramnath, A; Rawls, SM; Reitz, AB; Smith, GR; Tallarida, CS; Vouga, A | 1 |
| He, J; Hu, Z; Li, L; Su, H; Sun, Y; Tao, J; Xie, Y; Zhang, J; Zhang, XY | 1 |
| Doyle, SE; Feng, H; Garber, G; Lynch, WJ; Menaker, M | 1 |
| Karimian Sichani, N; Maracy, M; Mousavi, SG; Peykanpour, M; Salehi, M; Sharbafchi, MR | 1 |
| Davidson, C; Hutchinson, CV; Prados, J | 1 |
| Adhikary, S; Bossert, JM; Caprioli, D; Li, X; Lucantonio, F; Madangopal, R; Marchant, NJ; Schoenbaum, G; Shaham, Y; Venniro, M; Zeric, T | 1 |
| Chua, BE; Gundlach, AL; Haidar, M; Lam, M; Smith, CM | 1 |
| Chuanwei, L; Din, X; Haifeng, J; Haiming, S; Hong, C; Jiang, D; Jijun, W; Min, Z; Wenxu, Z; Zhikang, C | 1 |
| Lipinska, G; Thomas, KG; Timol, R | 1 |
| Magee, JC; Winhusen, T | 1 |
| Hashimoto, K; Ma, M; Ren, Q; Yang, C; Yao, W; Zhang, JC | 1 |
| Kim, JH; Liu, Y; Qiu, Y; Shen, HW; Xu, P; Zhang, Y; Βai, Y | 1 |
| Guo, J; He, J; Ren, W; Su, H; Tao, J; Wei, Y; Xie, Y; Zhang, H; Zhang, J; Zhang, X | 1 |
| Bailey, A; Garcia-Carmona, JA; Georgiou, P; Hourani, S; Kitchen, I; Laorden, ML; Zanos, P | 1 |
| Adhikary, S; Bossert, JM; Caprioli, D; Kallenberger, P; Shaham, Y; Venniro, M | 1 |
| Chen, PY; Chen, WY; Huang, MC; Kao, CF; Lin, SK | 1 |
| Christian, DT; Dolubizno, H; Le, T; Loweth, JA; Murray, CH; Rabei, R; Sakas, C; Scheyer, AF; Stefanik, MT; Uejima, J; Wolf, ME | 1 |
| Dean, AC; Jones, HW; London, ED; Price, KA | 1 |
| Hellem, TL | 1 |
| Brown, CN; Campbell, RR; Cohen, M; Fultz, EK; Kippin, TE; Klugmann, M; Lominac, KD; Martin, D; Miller, BW; Phillips, TJ; Quadir, SG; Szumlinski, KK; Thompson, AB; von Jonquieres, G | 1 |
| Bandegi, AR; Hajheidari, S; Miladi-Gorji, H; Sameni, HR | 1 |
| Acker, J; Patel, H; Phillips, AG; Raffa, RB; Rawls, SM; Sacavage, S; Zielinski, M | 1 |
| Chang, L; Ernst, T | 1 |
| Ding, Z; Gerber, K; Raffa, RB; Rawls, SM; Roth, C | 1 |
| Abraham, S; Neale, A; Russell, J | 1 |
| Montoya, ID; Vocci, F | 1 |
| Boileau, I; Guttman, M; Houle, S; Kish, SJ; Rusjan, P; Saint-Cyr, JA; Selby, P; Tong, J; Wilkins, D; Wilson, AA | 1 |
| Nabeshima, T; Niwa, M; Yan, Y | 1 |
| Galloway, GP; Leamon, MH; Moore, CD; Nordahl, TE; Salo, R; Waters, C | 1 |
| Heinzerling, K; Kao, U; Ling, W; Shoptaw, SJ | 1 |
| Cruickshank, CC; Dyer, KR | 1 |
| Booth, RE; Corsi, KF | 1 |
| Everhart, T; Harris, DS; Jacob, P; Jones, RT; Lin, E; Mendelson, JE | 1 |
| Cook, IA; De la Garza, R; Green, MF; Kalechstein, AD; Leuchter, AF; Newton, TF | 1 |
| Cahill, S; Harrison, S; Longo, M; Smout, M; White, JM; Wickes, W | 1 |
| Lee, NK; Pennay, AE | 2 |
| Brennan, KA; Carati, C; Colussi-Mas, J; Fitzmaurice, PS; Lea, RA; Schenk, S | 1 |
| Bartzokis, G; Dean, AC; Hudkins, M; London, ED; O'Neill, J; Tobias, MC | 1 |
| Baker, A; Ferris, J; Kay-Lambkin, F; Lee, NK; Pohlman, S | 1 |
| Kitanaka, J; Kitanaka, N; Morita, Y; Nishiyama, N; Takemura, M; Tanaka, K; Tatsuta, T; Watabe, K | 1 |
| Patil, T; Raffa, RB; Rawls, SM; Yuvasheva, E | 1 |
| Butler, TR; Prendergast, MA; Smith, KJ | 1 |
| Ayoub, G; Raffa, RB; Rawls, SM; Shah, H | 1 |
| Hellemann, G; London, ED; Miotto, K; Nestor, L; Rawson, R; Scanlon, G; Sugar, C; Zorick, T | 1 |
| Cottencin, O; Karila, L; Petit, A; Reynaud, M | 1 |
| Ferris, J; Hester, R; Lee, N; Nielsen, S; Pennay, A | 1 |
| Feldman, Z; Gentry, BW; Mancino, MJ; Mendelson, J; Oliveto, A | 1 |
| Gist, RS; Serianni, RP; Sullivan, M | 1 |
| Davies, S; Marsden, J; Mitcheson, L; Puchnarewicz, M; Ramsey, J; Winstock, A | 1 |
| Kitaichi, K; Nawata, Y; Yamamoto, T | 1 |
| Nelson, LS; Prosser, JM | 1 |
| Chang, LC; De La Garza, R; Jackson, BJ; Kalechstein, AD; Mahoney, JJ; Newton, TF | 1 |
| Greenberg, MI; Haggerty, DA; Miller, SN; Okaneku, JT; Vearrier, D | 1 |
| Bhatt, P; Lodi, S; Raffa, RB; Ramoz, L; Rawls, SM; Reitz, AB; Tallarida, C; Tallarida, RJ | 1 |
| Hellemann, G; Lee, B; London, ED; Morales, AM; O'Neill, J | 1 |
| Ferris, J; Hester, R; Lee, N; McKetin, R; Nielsen, S; Pennay, A | 1 |
| Nawata, Y; Yamaguchi, T; Yamamoto, T | 1 |
| Cottencin, O; Guardia, D; Karila, L; Rolland, B | 1 |
| London, ED; McCracken, JT; Nurmi, EL; Payer, DE; Wilson, SA | 1 |
| Akins, CK; Bolin, BL | 1 |
| Jang, CG; Koob, GF; Schulteis, G; Wee, S; Whitfield, T | 1 |
| Avila, A; Cuenod, BA; Frohardt, RJ; Guarraci, FA; Memos, N; Navarro, A; Ornelas, LC; Romero, J; Scheible, M; Schumacher, A; Thibodeau, RB; Zimmermann, K | 1 |
| Adalsteinsson, E; Flynn, N; Galloway, GP; Gibson, DR; Leamon, M; Nordahl, TE; Pfefferbaum, A; Possin, K; Salo, R; Spielman, DM; Sullivan, EV | 1 |
| Kondo, N; Minabe, Y; Mori, N; Sekine, Y; Takei, N; Won, M | 1 |
| Kono, J; Miyata, H; Yanagita, T | 1 |
| Cook, IA; Duran, S; Kalechstein, AD; Leuchter, AF; Ling, W; Monroy, F; Newton, TF | 1 |
| PROUT, CT | 1 |
| Berman, SM; Bramen, J; Dong, Y; Kurian, V; Learn, J; Lichtman, AM; Ling, W; London, ED; Mandelkern, MA; Matochik, JA; Miotto, K; Newton, T; Rawson, R; Shinn, AK; Simon, SL; Woods, R | 1 |
| Grimm, JW; Hope, BT; Lu, L; Shaham, Y | 1 |
| Flynn, CT; Fox, HS; Henriksen, SJ; Katner, SN; Madden, LJ; May, M; Parsons, LH; Zandonatti, MA | 1 |
| Davidson, C; Ellinwood, EH; Lee, TH | 1 |
| Chang, YP; Yen, CF | 1 |
| Chew, G; Fernando, A | 1 |
| Akiskal, HS; Camacho, A | 1 |
| Buonocore, MH; Galloway, GP; Kile, S; Moore, CD; Natsuaki, Y; Nordahl, TE; Salo, R; Waters, C | 1 |
| Broom, SL; Yamamoto, BK | 1 |
| Berman, SM; Brody, AL; Geaga, JA; Hayashi, KM; Hong, MS; Ling, W; London, ED; Mandelkern, MA; Monterosso, J; Rawson, RA; Simon, SL; Thompson, PM; Voytek, B | 1 |
| Jittiwutikarn, J; Laobhripatr, S; McGregor, C; Srisurapanont, M; White, JM; Wongtan, T | 1 |
| Futatsubashi, M; Iwata, Y; Iyo, M; Minabe, Y; Mori, N; Nakamura, K; Okada, H; Ouchi, Y; Sekine, Y; Suzuki, K; Takei, N; Tsuchiya, KJ; Tsukada, H; Yoshikawa, E | 1 |
| Chuang, DT; Morales, M; Shaham, Y; Shepard, JD | 1 |
| Huber, A; Ling, W; Liu, J; Peck, J; Roll, J; Rotheram-Fuller, E; Shapiro, B; Shoptaw, S; Yang, X | 1 |
| Hoefer, ME; Koob, GF; Pulvirenti, L; Voskanian, SJ | 1 |
| Romanelli, F; Smith, KM | 1 |
| Ling, W; Rawson, R; Shoptaw, S | 1 |
| Bruce, CC; Dalley, JW; Everitt, BJ; Huszar, AC; Lääne, K; Peña, Y; Robbins, TW; Theobald, DE; Wojcieszek, M | 1 |
| Ali, SF; Sharma, HS | 1 |
| Grasing, K; He, S | 1 |
| Bruehl, AM; Elifson, K; Lende, DH; Schwartz, M; Sterk, CE | 1 |
| Ahn, C; Chen, Q; Davidson, C; Ellinwood, EH; Gopalan, R; Lee, TH; Mannelli, P; Patkar, AA; Weese, GD | 1 |
| Ali, SF; Sharma, HS; Sjöquist, PO | 1 |
| Cherrier, M; Jaffe, C; Meredith, CW; Saxon, AJ; Yanasak, E | 1 |
| Berman, SM; Hassid, BD; Isaacson, A; Ling, W; London, ED; Mandelkern, MA; Miotto, K; Monterosso, J; Voytek, B | 1 |
| Chen, JC; Chiang, YC | 1 |
| Braden, BB; Butler, TR; Prendergast, MA; Self, RL; Smith, KJ | 1 |
| Capasso, A; Cavallo, F; Ding, Z; Raffa, RB; Rawls, SM | 1 |
| Blaszczyk, J; Cruickshank, CC; Dyer, KR; Montebello, ME; Quigley, A; Shand, D; Tomkins, S | 1 |
| Marris, E | 1 |
| Baron, S; Ding, Z; Raffa, RB; Rawls, SM; Roth, C; Zaveri, N | 1 |
| Kampman, KM | 1 |
| Bogenschutz, MP; DeMarzo, LJ; Roll, J | 1 |
| Lake, CR; Quirk, RS | 1 |
| Hiramori, T; Tagashira, E; Urano, T; Yanaura, S | 1 |
| Kadokawa, T; Karasawa, T; Masuda, Y; Ohi, K; Taga, C; Takahashi, S; Tsuji, M; Yamada, N | 1 |
| Akiyama, K; Chen, CC; Otsuki, S; Sato, M | 1 |
| Raskin, DE | 1 |
| Yamamoto, K; Yoshimura, K | 1 |
| Dall'Olio, R; Gandolfi, O; Montanaro, N; Vaccheri, A | 1 |
| Hongcheng, B; Islam, MN; Kawaguchi, N; Kuroki, H; Ogura, Y; Onishi, S; Wakasugi, C | 1 |
| McCann, MJ; Obert, JL; Rawson, RA; Shoptaw, S | 1 |
| Galloway, GP; Knapp, T; Newmeyer, J; Smith, D; Stalcup, SA | 1 |
| Gillin, JC; Golshan, S; Koob, G; Pulvirenti, L; Withers, N | 1 |
| Hatake, K; Hishida, S; Ouchi, H; Taniguchi, T; Yamamura, T | 1 |
| Egashira, T; Yamanaka, Y | 1 |
| Angulo, JA; Zhang, Y | 1 |
| Murray, JB | 1 |
| Anglin, MD; Gawin, FH; Kalechstein, AD; Longshore, D; Newton, TF; van Gorp, WG | 1 |
| Angulo, JA; Loonam, TM; Noailles, PA; Zhang, Y | 1 |
| Hukui, K; Ikawa, G; Kono, J; Miyasato, K; Miyata, H; Ushijima, S; Yanagita, T | 1 |
| Jarusuraisin, N; Kittirattanapaiboon, P; Srisurapanont, M | 1 |
| Cadet, JL; Goldberg, SR; Lee, SH; Stefanski, R; Yasar, S | 1 |
| Chang, L; DeSilva, M; Ernst, T; Leonido-Yee, M; Miller, EN; Patel, H; Speck, O | 1 |
| Seltzer, V; Tonge, SR | 1 |
| Hakkei, M; Kubota, A; Kuwahara, A; Nakamura, K | 1 |
| Feer, H; Kraeuchi, K; Rudolph, K; Wirz-Justice, A | 1 |
| Hartmann, E; Schildkraut, JJ; Watson, R | 1 |
| Kamei, C; Shimomura, K; Ueki, S | 1 |
| Bachelard, HS; Manning, DH; Strang, RH | 1 |
| Fischer, CM; Smith, DE | 1 |
27 review(s) available for methamphetamine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Understanding Stimulant Use and Use Disorders in a New Era.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anticonvulsants; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Dysfunction; Comorbidity; Dopamine Uptake Inhibitors; Female; Humans; Illicit Drugs; Male; Mental Disorders; Methamphetamine; Mirtazapine; Neurobiology; Neurodegenerative Diseases; Opiate Overdose; Substance Withdrawal Syndrome; Topiramate; Transgender Persons; United States | 2022 |
Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials.
Topics: Female; Humans; Male; Methamphetamine; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2023 |
Clinical management of psychostimulant withdrawal: review of the evidence.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine; Humans; Methamphetamine; Substance Withdrawal Syndrome | 2023 |
Neural mechanisms underlying incubation of methamphetamine craving: A mini-review.
Topics: Animals; Central Nervous System Stimulants; Drug-Seeking Behavior; Humans; Male; Methamphetamine; Motivation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2020 |
Compulsive methamphetamine taking and abstinence in the presence of adverse consequences: Epigenetic and transcriptional consequences in the rat brain.
Topics: Animals; Brain; Epigenesis, Genetic; Methamphetamine; Rats; Substance Withdrawal Syndrome; Transcription, Genetic | 2019 |
Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.
Topics: Amphetamine-Related Disorders; Animals; Cannabidiol; Cocaine-Related Disorders; Health Risk Behaviors; Humans; Methamphetamine; Mice; Observational Studies as Topic; Resilience, Psychological; Substance Withdrawal Syndrome | 2019 |
[Mephedrone: a new synthetic drug].
Topics: Adult; Central Nervous System Stimulants; Europe; France; Humans; Illicit Drugs; Methamphetamine; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult | 2013 |
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome | 2013 |
Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Energy Metabolism; Humans; Inflammation Mediators; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Stress; Recurrence; Substance Withdrawal Syndrome | 2014 |
A Review of Methamphetamine Dependence and Withdrawal Treatment: A Focus on Anxiety Outcomes.
Topics: Amphetamine-Related Disorders; Anxiety Disorders; Central Nervous System Stimulants; Humans; Methamphetamine; Outcome Assessment, Health Care; Substance Withdrawal Syndrome | 2016 |
Novel medications to treat addictive disorders.
Topics: Amphetamine-Related Disorders; Brain; Cocaine-Related Disorders; Humans; Illicit Drugs; Marijuana Abuse; Methamphetamine; Neurotransmitter Agents; Opioid-Related Disorders; Psychotropic Drugs; Substance Withdrawal Syndrome; Substance-Related Disorders | 2008 |
Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
Topics: Adaptation, Physiological; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Classical; Discrimination Learning; Drug Tolerance; Genetic Predisposition to Disease; Humans; Methamphetamine; Mice; Models, Animal; Motor Activity; Nerve Tissue Proteins; Rats; Self Administration; Species Specificity; Substance Withdrawal Syndrome; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha | 2008 |
Treatment for amphetamine withdrawal.
Topics: Amphetamine; Antidepressive Agents, Tricyclic; Dextroamphetamine; Dibenzocycloheptenes; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2009 |
A review of the clinical pharmacology of methamphetamine.
Topics: Amphetamine-Related Disorders; Cardiovascular Diseases; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Half-Life; Humans; Methamphetamine; Randomized Controlled Trials as Topic; Risk Factors; Substance Withdrawal Syndrome | 2009 |
HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Comorbidity; Cross-Sectional Studies; Euphoria; Female; Hepatitis C, Chronic; Heterosexuality; HIV Infections; Humans; Male; Methamphetamine; Sexual Behavior; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; United States; Unsafe Sex; Young Adult | 2008 |
Management of substance abuse in the hospital setting.
Topics: Alcoholism; Amphetamine-Related Disorders; Anesthesiology; Cocaine-Related Disorders; Hospitals; Humans; Methamphetamine; Opioid-Related Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders | 2011 |
Putting the call out for more research: the poor evidence base for treating methamphetamine withdrawal.
Topics: Amphetamine-Related Disorders; Biomedical Research; Evidence-Based Medicine; Humans; Methamphetamine; Substance Withdrawal Syndrome; Treatment Outcome | 2011 |
The toxicology of bath salts: a review of synthetic cathinones.
Topics: Alkaloids; Humans; Illicit Drugs; Methamphetamine; Prevalence; Psychotropic Drugs; Substance Withdrawal Syndrome; Substance-Related Disorders | 2012 |
Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Designer Drugs; Drug Administration Routes; Drug and Narcotic Control; Hazardous Substances; History, 20th Century; Humans; Illicit Drugs; Methamphetamine; Organs at Risk; Pharmacoepidemiology; Social Problems; Substance Withdrawal Syndrome; Sympathomimetics | 2012 |
[Current data on methamphetamine].
Topics: Central Nervous System Stimulants; Humans; Illicit Drugs; Methamphetamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 2012 |
Incubation of cocaine craving after withdrawal: a review of preclinical data.
Topics: Amphetamine-Related Disorders; Animals; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; Cocaine-Related Disorders; Cues; Dopamine; Generalization, Psychological; Methamphetamine; Neuropeptides; Rats; Recurrence; Substance Withdrawal Syndrome | 2004 |
Clinical effects and management of methamphetamine abuse.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Drug and Narcotic Control; History, 20th Century; Humans; Methamphetamine; Substance Withdrawal Syndrome | 2006 |
Management of methamphetamine abuse and dependence.
Topics: Baclofen; Benzhydryl Compounds; Brain; Bupropion; Cognition Disorders; Cognitive Behavioral Therapy; Humans; Methamphetamine; Modafinil; Nerve Net; Substance Withdrawal Syndrome; Substance-Related Disorders | 2006 |
Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
Topics: Amphetamine-Related Disorders; Animals; Antioxidants; Blood-Brain Barrier; Central Nervous System Stimulants; Fever; Humans; Indoles; Methamphetamine; Morphine Dependence; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotransmitter Agents; Oxidative Stress; Reactive Oxygen Species; Substance Withdrawal Syndrome; Substance-Related Disorders | 2007 |
Psychophysiological aspects of amphetamine-methamphetamine abuse.
Topics: Amphetamine-Related Disorders; Amphetamines; Behavior, Addictive; Humans; Methamphetamine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome | 1998 |
Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Glutamic Acid; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substantia Nigra | 2001 |
Treatment for amphetamine withdrawal.
Topics: Amphetamine; Clinical Trials as Topic; Dextroamphetamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Substance Withdrawal Syndrome | 2001 |
25 trial(s) available for methamphetamine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Female; Humans; Male; Methamphetamine; Pilot Projects; Substance Withdrawal Syndrome; Young Adult | 2021 |
[
Topics: Abdomen; Acupuncture Points; Acupuncture Therapy; Depression; Female; Humans; Methamphetamine; Sleep Quality; Substance Withdrawal Syndrome; Treatment Outcome | 2022 |
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.
Topics: Alcoholism; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methamphetamine; Pilot Projects; Substance Withdrawal Syndrome; Treatment Outcome | 2022 |
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.
Topics: Adult; Alcoholism; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Lisdexamfetamine Dimesylate; Male; Methamphetamine; Pilot Projects; Substance Withdrawal Syndrome; Treatment Outcome | 2022 |
The 5-HT
Topics: Adult; Alcohol Drinking; Alcoholics; Anti-Obesity Agents; Benzazepines; Female; Humans; Male; Methamphetamine; Middle Aged; Obesity; Pilot Projects; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders | 2021 |
Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Topics: Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Central Nervous System Stimulants; Craving; Double-Blind Method; Humans; Iran; Male; Methadone; Methamphetamine; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult | 2017 |
Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Central Nervous System Stimulants; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Heroin; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Pyrazoles; Receptors, Corticotropin-Releasing Hormone; Severity of Illness Index; Substance Abuse Detection; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome; Triazines; Visual Analog Scale | 2018 |
Electro-acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence: A randomized controlled trial.
Topics: Acupuncture Points; Adult; Anxiety; China; Depression; Electroacupuncture; Female; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Single-Blind Method; Substance Withdrawal Syndrome | 2018 |
Targeting Withdrawal Symptoms in Men Addicted to Methamphetamine With Transcranial Magnetic Stimulation: A Randomized Clinical Trial.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Central Nervous System Stimulants; Double-Blind Method; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome; Transcranial Magnetic Stimulation; Treatment Outcome; Young Adult | 2018 |
A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Bupropion; Central Nervous System Stimulants; Craving; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Iran; Male; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult | 2019 |
[Comparative study on effects between electroacupuncture and auricular acupuncture for methamphetamine withdrawal syndrome].
Topics: Acupuncture Points; Acupuncture, Ear; Adult; Electroacupuncture; Female; Humans; Male; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2014 |
The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Topics: Acetylcysteine; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Craving; Cross-Over Studies; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2015 |
The coupling of nicotine and stimulant craving during treatment for stimulant dependence.
Topics: Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Craving; Humans; Methamphetamine; Models, Psychological; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Treatment Outcome | 2016 |
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
Topics: Administration, Cutaneous; Adult; Affect; Amphetamine; Amphetamines; Analysis of Variance; Cocaine; Dopamine Uptake Inhibitors; Drug Interactions; Female; Homovanillic Acid; Humans; Infusions, Intravenous; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Monitoring, Physiologic; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Prolactin; Selegiline; Statistics, Nonparametric; Substance Withdrawal Syndrome; Young Adult | 2009 |
Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Delayed-Action Preparations; Dextroamphetamine; Double-Blind Method; Female; Hair; Humans; Kaplan-Meier Estimate; Male; Methamphetamine; Patient Acceptance of Health Care; Patient Dropouts; Severity of Illness Index; South Australia; Substance Abuse Detection; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2010 |
It's the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use.
Topics: Amphetamine-Related Disorders; Awareness; Cognitive Behavioral Therapy; Counseling; Follow-Up Studies; Humans; Internal-External Control; Judgment; Methamphetamine; Motivation; New South Wales; Patient Dropouts; Queensland; Substance Withdrawal Syndrome; Surveys and Questionnaires; Temperance | 2010 |
The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Attention; Benzhydryl Compounds; Central Nervous System Stimulants; Double-Blind Method; Executive Function; Female; Follow-Up Studies; Humans; Male; Memory; Methamphetamine; Middle Aged; Modafinil; Neuropsychological Tests; Pilot Projects; Recurrence; Stroop Test; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2010 |
Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers.
Topics: Adult; Amphetamine-Related Disorders; Benzhydryl Compounds; Central Nervous System Stimulants; Cognition; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Methamphetamine; Modafinil; Neuropsychological Tests; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Wake Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2012 |
A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
Topics: Adult; Amphetamine-Related Disorders; Benzhydryl Compounds; Central Nervous System Stimulants; Double-Blind Method; Feasibility Studies; Female; Humans; Male; Methamphetamine; Middle Aged; Modafinil; Pilot Projects; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2013 |
Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence.
Topics: Adult; Continuity of Patient Care; Demography; Depression; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Length of Stay; Male; Methamphetamine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2006 |
An open-label pilot study of risperidone in the treatment of methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Substance Withdrawal Syndrome; United States; Veterans | 2007 |
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Topics: Adult; Ambulatory Care; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methamphetamine; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors | 2008 |
The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.
Topics: Adult; Ambulatory Care; Cocaine; Combined Modality Therapy; Desipramine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methamphetamine; Neurologic Examination; Patient Care Team; Socioenvironmental Therapy; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome | 1994 |
Imipramine for the treatment of cocaine and methamphetamine dependence.
Topics: Cocaine; Combined Modality Therapy; Counseling; Dose-Response Relationship, Drug; Double-Blind Method; Feasibility Studies; Female; Follow-Up Studies; Humans; Imipramine; Male; Methamphetamine; Patient Dropouts; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome | 1994 |
The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report.
Topics: Administration, Oral; Adult; Affect; Brain; Cocaine; Crack Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Male; Methamphetamine; Middle Aged; Neurologic Examination; Receptors, Dopamine; Sleep, REM; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
149 other study(ies) available for methamphetamine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Leukocyte telomere length is not shortened in methamphetamine dependence or methamphetamine-induced psychosis but is increased following traumatic events.
Topics: Alcoholism; Amphetamine-Related Disorders; Humans; Leukocytes; Methamphetamine; Psychotic Disorders; Substance Withdrawal Syndrome; Telomere; Tobacco Use Disorder | 2022 |
Psychiatric Comorbidities and Liver Injury Are Associated With Unbalanced Plasma Bile Acid Profile During Methamphetamine Withdrawal.
Topics: Adult; Bile Acids and Salts; Humans; Liver; Male; Mental Disorders; Methamphetamine; Middle Aged; Retrospective Studies; Substance Withdrawal Syndrome | 2021 |
Dynamics and correlations in multiplex immune profiling reveal persistent immune inflammation in male drug users after withdrawal.
Topics: Cytokines; Drug Users; Heroin; Humans; Inflammation; Male; Methamphetamine; Substance Withdrawal Syndrome | 2022 |
Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Depression; Inosine; Metformin; Methamphetamine; Mice; Microbiota; Rats; Substance Withdrawal Syndrome | 2022 |
Metformin attenuates depressive-like behaviour of methamphetamine withdrawal in mice: A mechanistic approach.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Male; Methamphetamine; Mice; Substance Withdrawal Syndrome | 2023 |
Specific Inhibition of Interpeduncular Nucleus GABAergic Neurons Alleviates Anxiety-Like Behaviors in Male Mice after Prolonged Abstinence from Methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; GABAergic Neurons; Interpeduncular Nucleus; Male; Methamphetamine; Mice; Substance Withdrawal Syndrome | 2023 |
Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder.
Topics: Amphetamine-Related Disorders; Appetite; Gastrointestinal Microbiome; Humans; Methamphetamine; Substance Withdrawal Syndrome | 2023 |
Gegen-Qinlian decoction-A traditional Chinese medicine formula-Alleviates methamphetamine withdrawal induced anxiety by targeting GABAergic interneuron-pyramidal neuron pathway in mPFC.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; gamma-Aminobutyric Acid; Interneurons; Medicine, Chinese Traditional; Methamphetamine; Mice; Pyramidal Cells; Substance Withdrawal Syndrome | 2023 |
Proteomic Analysis Reveals the Neurotoxic Effects of Chronic Methamphetamine Self-Administration-Induced Cognitive Impairments and the Role of Melatonin-Enhanced Restorative Process during Methamphetamine Withdrawal.
Topics: Animals; Cognitive Dysfunction; Humans; Melatonin; Methamphetamine; Mice; Proteomics; Substance Withdrawal Syndrome | 2023 |
Integrated Non-targeted and Targeted Metabolomics Uncovers Dynamic Metabolic Effects during Short-Term Abstinence in Methamphetamine Self-Administering Rats.
Topics: Amino Acids; Animals; Chromatography, Liquid; Energy Metabolism; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Methamphetamine; Principal Component Analysis; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome; Time Factors | 2019 |
Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Craving; Cues; Feasibility Studies; Female; Humans; Male; Methamphetamine; Middle Aged; Patient Acceptance of Health Care; Reward; Substance Withdrawal Syndrome; Therapy, Computer-Assisted; Treatment Outcome; Young Adult | 2019 |
Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression; Male; Methamphetamine; Nucleus Accumbens; Orexin Receptors; Rats; Rats, Long-Evans; Receptors, Opioid; RNA, Messenger; Sex Characteristics; Substance Withdrawal Syndrome; Vasopressins | 2019 |
Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cognition; Cognition Disorders; Cohort Studies; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Substance Withdrawal Syndrome; Time Factors; Young Adult | 2019 |
The association between interleukin-8 levels and the development of withdrawal symptoms during methamphetamine abstinence.
Topics: Adult; Amphetamine-Related Disorders; Female; Follow-Up Studies; Humans; Interleukin-8; Male; Methamphetamine; Prospective Studies; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2020 |
Differences in serum orexin-A levels between the acute and subacute withdrawal phases in individuals who use methamphetamine.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Drug-Seeking Behavior; Female; Humans; Male; Methamphetamine; Orexins; Substance Withdrawal Syndrome | 2021 |
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Depression; Disease Models, Animal; Endocannabinoids; Male; Methamphetamine; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substance Withdrawal Syndrome; TRPV Cation Channels | 2021 |
Altered patterns of fractional amplitude of low-frequency fluctuation and regional homogeneity in abstinent methamphetamine-dependent users.
Topics: Adult; Brain Mapping; Case-Control Studies; Female; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome | 2021 |
Factors associated with methamphetamine withdrawal symptoms among people who inject drugs.
Topics: Female; HIV Infections; Humans; Methamphetamine; Needle Sharing; Pharmaceutical Preparations; Risk-Taking; Substance Abuse, Intravenous; Substance Withdrawal Syndrome | 2021 |
Functional connectivity abnormalities underlying mood disturbances in male abstinent methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Cerebral Cortex; Connectome; Depression; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Nerve Net; Substance Withdrawal Syndrome; White Matter; Young Adult | 2021 |
The effects of minocycline in improving of methamphetamine withdrawal syndrome in male mice.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Male; Methamphetamine; Mice; Minocycline; Substance Withdrawal Syndrome | 2022 |
Topics: Analgesics, Opioid; Fentanyl; Humans; Methamphetamine; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2021 |
Effect of Chaihu-jia-Longgu-Muli decoction on withdrawal symptoms in rats with methamphetamine-induced conditioned place preference.
Topics: Animals; Behavior, Animal; beta-Endorphin; Central Nervous System Stimulants; Conditioning, Psychological; Corpus Striatum; Disease Models, Animal; Dopamine; Drugs, Chinese Herbal; Interleukin-1alpha; Interleukin-2; Male; Methamphetamine; Open Field Test; Rats, Sprague-Dawley; Serotonin; Substance Withdrawal Syndrome | 2021 |
Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Young Adult | 2017 |
Steep effort discounting of a preferred reward over a freely-available option in prolonged methamphetamine withdrawal in male rats.
Topics: Animals; Central Nervous System Stimulants; Choice Behavior; Delay Discounting; Male; Methamphetamine; Motivation; Rats; Rats, Long-Evans; Reward; Substance Withdrawal Syndrome; Time Factors | 2017 |
Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal.
Topics: Adult; Amphetamine-Related Disorders; Brain-Derived Neurotrophic Factor; Case-Control Studies; Depression; Female; Humans; Male; Methamphetamine; Risk Assessment; Substance Withdrawal Syndrome; Young Adult | 2017 |
Methamphetamine binge administration dose-dependently enhanced negative affect and voluntary drug consumption in rats following prolonged withdrawal: role of hippocampal FADD.
Topics: Animals; Biogenic Monoamines; Biomarkers; Brain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Fas-Associated Death Domain Protein; Hippocampus; Male; Methamphetamine; Rats, Sprague-Dawley; Stress, Psychological; Substance Withdrawal Syndrome; Swimming; Weight Loss | 2019 |
Role of Dorsal Striatum Histone Deacetylase 5 in Incubation of Methamphetamine Craving.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Craving; Drug-Seeking Behavior; Gene Knockdown Techniques; Histone Deacetylases; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome | 2018 |
Prescription drug diversion is becoming a lucrative business in regional and rural Australian communities and is escalating due to methamphetamine withdrawal.
Topics: Amphetamine-Related Disorders; Australia; Humans; Methamphetamine; Prescription Drug Diversion; Rural Population; Substance Withdrawal Syndrome | 2018 |
Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Attention; Brain Mapping; Brain Waves; Central Nervous System Stimulants; Child; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; Photic Stimulation; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2019 |
Persistent effect of withdrawal from intravenous methamphetamine self-administration on brain activation and behavioral economic indices involving an effort cost.
Topics: Administration, Intravenous; Animals; Basolateral Nuclear Complex; Choice Behavior; Decision Making; Male; Methamphetamine; Physical Exertion; Rats; Self Administration; Substance Withdrawal Syndrome; Ventral Striatum | 2018 |
The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Psychological; Corpus Striatum; Dopaminergic Neurons; Gene Knockout Techniques; Male; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Period Circadian Proteins; Postural Balance; Protease Inhibitors; Reward; Substance Withdrawal Syndrome | 2019 |
Association between serum malondialdehyde levels and depression during early methamphetamine withdrawal.
Topics: Adult; Amphetamine-Related Disorders; Biomarkers; Central Nervous System Stimulants; Depression; Female; Humans; Male; Malondialdehyde; Methamphetamine; Substance Withdrawal Syndrome; Young Adult | 2018 |
Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake.
Topics: Animals; Central Nervous System Stimulants; Depression; Disease Models, Animal; Female; Male; Methamphetamine; Mice; Mice, Inbred DBA; Substance Withdrawal Syndrome | 2019 |
Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Depression; Disease Models, Animal; Hippocampus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Substance Withdrawal Syndrome | 2019 |
The Stimulant Selective Severity Assessment: A replication and exploratory extension of the Cocaine Selective Severity Assessment.
Topics: Adult; Central Nervous System Stimulants; Cocaine; Craving; Female; Humans; Male; Methamphetamine; Middle Aged; Severity of Illness Index; Substance Withdrawal Syndrome; Young Adult | 2019 |
MMP-9-BDNF pathway is implicated in cognitive impairment of male individuals with methamphetamine addiction during early withdrawal.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Drug Users; Humans; Male; Matrix Metalloproteinase 9; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders | 2019 |
Stress-induced neural activation is altered during early withdrawal from chronic methamphetamine.
Topics: Animals; Anxiety; Brain; CA3 Region, Hippocampal; Central Nervous System Stimulants; Corticosterone; Depression; Exercise Test; Female; Hypothalamo-Hypophyseal System; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Stress, Physiological; Substance Withdrawal Syndrome; Swimming | 2019 |
AMPA receptor and metabotropic glutamate receptor 1 adaptations in the nucleus accumbens core during incubation of methamphetamine craving.
Topics: Allosteric Regulation; Amphetamine-Related Disorders; Animals; Craving; Cues; Homer Scaffolding Proteins; Methamphetamine; Nucleus Accumbens; Protein Biosynthesis; Rats; Receptors, AMPA; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome | 2019 |
Distinct gene alterations between Fos-expressing striatal and thalamic neurons after withdrawal from methamphetamine self-administration.
Topics: Animals; Corpus Striatum; Craving; Disease Models, Animal; Gene Expression Regulation; Male; Methamphetamine; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome; Thalamus | 2019 |
Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
Topics: Amino Acids; Analysis of Variance; Animals; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Interactions; Excitatory Amino Acid Antagonists; Immobility Response, Tonic; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Swimming; Xanthenes | 2013 |
Cellular distribution of AMPA receptor subunits and mGlu5 following acute and repeated administration of morphine or methamphetamine.
Topics: Analgesics, Opioid; Animals; Blotting, Western; Brain Chemistry; Central Nervous System Stimulants; Globus Pallidus; Male; Methamphetamine; Morphine; Nucleus Accumbens; Prefrontal Cortex; Protein Tyrosine Phosphatases, Non-Receptor; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome | 2013 |
Methamphetamine-withdrawal stress activates PACAP-DBI pathway in rat salivary gland, resulting in inhibition of salivary secretion.
Topics: Animals; Catheterization; Depression, Chemical; Diazepam Binding Inhibitor; GABA-A Receptor Agonists; Male; Methamphetamine; Pituitary Adenylate Cyclase-Activating Polypeptide; Pituitary Gland; Pregnenolone; Rats; Rats, Wistar; Salivary Glands; Salivation; Signal Transduction; Substance Withdrawal Syndrome | 2013 |
Combinations of oxazepam and metyrapone attenuate cocaine and methamphetamine cue reactivity.
Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Central Nervous System Stimulants; Cocaine-Related Disorders; Conditioning, Operant; Corticosterone; Cues; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Food; Hypnotics and Sedatives; Male; Methamphetamine; Metyrapone; Oxazepam; Pharmaceutical Vehicles; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome | 2013 |
Withdrawal from long-term methamphetamine self-administration 'normalizes' neurometabolites in rhesus monkeys: a (1) H MR spectroscopy study.
Topics: Animals; Brain; Caudate Nucleus; Central Nervous System Stimulants; Glutamic Acid; Glutamine; Gyrus Cinguli; Inositol; Longitudinal Studies; Macaca mulatta; Methamphetamine; Proton Magnetic Resonance Spectroscopy; Putamen; Self Administration; Substance Withdrawal Syndrome | 2015 |
A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Gene Expression Regulation; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Pregnanolone; Rats; Rats, Long-Evans; Receptors, GABA-A; Sensory Gating; Stress, Psychological; Substance Withdrawal Syndrome | 2013 |
Different levels in orexin concentrations and risk factors associated with higher orexin levels: comparison between detoxified opiate and methamphetamine addicts in 5 Chinese cities.
Topics: Adult; China; Cross-Sectional Studies; Female; Humans; Inactivation, Metabolic; Intracellular Signaling Peptides and Proteins; Male; Methamphetamine; Neuropeptides; Opioid-Related Disorders; Orexins; Risk Factors; Substance Withdrawal Syndrome | 2013 |
Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Central Nervous System Stimulants; Drug Administration Schedule; Female; HIV Envelope Protein gp120; Humans; Lameness, Animal; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neural Inhibition; Reflex, Startle; Sex Factors; Substance Withdrawal Syndrome; Time Factors | 2014 |
Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Exploratory Behavior; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Male; MAP Kinase Signaling System; Memory Disorders; Methamphetamine; Mice, Inbred C57BL; Modafinil; Motor Activity; Neuropsychological Tests; Nootropic Agents; Nucleus Accumbens; Phosphorylation; Prefrontal Cortex; Recognition, Psychology; Substance Withdrawal Syndrome; Visual Perception | 2014 |
Prevalence and correlates of depressive symptoms during early methamphetamine withdrawal in Han Chinese population.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Asian People; China; Depression; Female; Humans; Male; Methamphetamine; Middle Aged; Prevalence; Risk Factors; Socioeconomic Factors; Substance Withdrawal Syndrome; Young Adult | 2014 |
Effect of the environmental enrichment on the severity of psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Depression; Environment; Male; Methamphetamine; Rats, Wistar; Substance Withdrawal Syndrome | 2015 |
The central amygdala nucleus is critical for incubation of methamphetamine craving.
Topics: Amphetamine-Related Disorders; Animals; Baclofen; Basolateral Nuclear Complex; Central Amygdaloid Nucleus; Central Nervous System Stimulants; Craving; Cues; Disease Models, Animal; Drug-Seeking Behavior; Frontal Lobe; GABA Agonists; Methamphetamine; Muscimol; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome | 2015 |
Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.
Topics: Animals; Cocaine; Conditioning, Psychological; Methamphetamine; Movement; Planarians; Reward; Stereotyped Behavior; Substance Withdrawal Syndrome | 2015 |
Relationship of impulsivity and depression during early methamphetamine withdrawal in Han Chinese population.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Central Nervous System Stimulants; China; Cross-Sectional Studies; Depression; Female; Humans; Impulsive Behavior; Male; Methamphetamine; Substance Withdrawal Syndrome | 2015 |
Effects of circadian disruption on methamphetamine consumption in methamphetamine-exposed rats.
Topics: Animals; Body Weight; Central Nervous System Stimulants; Choice Behavior; Circadian Rhythm; Jet Lag Syndrome; Male; Methamphetamine; Motor Activity; Photoperiod; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2015 |
Persistent conditioned place preference to cocaine and withdrawal hypo-locomotion to mephedrone in the flatworm planaria.
Topics: Animals; Cocaine; Conditioning, Psychological; Disease Models, Animal; Locomotion; Methamphetamine; Planarians; Psychotropic Drugs; Substance Withdrawal Syndrome; Substance-Related Disorders | 2015 |
Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Craving; Cues; Disease Models, Animal; Drug-Seeking Behavior; Excitatory Amino Acid Agents; Extinction, Psychological; Food; Indoles; Methamphetamine; Oxadiazoles; Rats; Receptors, Metabotropic Glutamate; Self Administration; Substance Withdrawal Syndrome; Time Factors; Volition | 2015 |
Sensitivity to Chronic Methamphetamine Administration and Withdrawal in Mice with Relaxin-3/RXFP3 Deficiency.
Topics: Anhedonia; Animals; Anxiety; Body Weight; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Exploratory Behavior; Methamphetamine; Mice; Mice, Knockout; Receptors, G-Protein-Coupled; Relaxin; Social Behavior; Substance Withdrawal Syndrome | 2016 |
P300 event-related potential in abstinent methamphetamine-dependent patients.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Electroencephalography; Event-Related Potentials, P300; Female; Humans; Longitudinal Studies; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Photic Stimulation; Reaction Time; Substance Withdrawal Syndrome; Visual Analog Scale; Young Adult | 2015 |
Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Depression; Environment; Exploratory Behavior; Male; Maze Learning; Methamphetamine; Motor Activity; Rats, Wistar; Stereotyped Behavior; Substance Withdrawal Syndrome | 2015 |
The implications of sleep disruption for cognitive and affective processing in methamphetamine abuse.
Topics: Behavior; Brain; Central Nervous System Stimulants; Cognition; Cognition Disorders; Emotions; Humans; Memory; Methamphetamine; Reward; Sleep; Sleep Wake Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders | 2015 |
BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Blotting, Western; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Protein Kinases; Signal Transduction; Substance Withdrawal Syndrome | 2015 |
The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine.
Topics: Amphetamines; Animals; Anxiety; Central Nervous System Agents; Conditioning, Psychological; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; Propiophenones; Rats, Sprague-Dawley; Reward; Spatial Behavior; Substance Withdrawal Syndrome | 2016 |
Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal.
Topics: Adult; Amphetamine-Related Disorders; Brain-Derived Neurotrophic Factor; Case-Control Studies; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome; Time Factors | 2016 |
Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
Topics: Amphetamine-Related Disorders; Amygdala; Animals; Anxiety; Central Nervous System Stimulants; Corpus Striatum; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Methamphetamine; Mice, Inbred C57BL; Neurons; Proto-Oncogene Proteins c-fos; Random Allocation; Receptors, Dopamine D2; Receptors, Opioid, mu; Receptors, Oxytocin; Septum of Brain; Substance Withdrawal Syndrome | 2016 |
Incubation of extinction responding and cue-induced reinstatement, but not context- or drug priming-induced reinstatement, after withdrawal from methamphetamine.
Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Craving; Cues; Disease Models, Animal; Extinction, Psychological; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2017 |
Orexin-A level elevation in recently abstinent male methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Biomarkers; Humans; Male; Methamphetamine; Orexins; Substance Withdrawal Syndrome; Young Adult | 2016 |
AMPA Receptor Plasticity in Accumbens Core Contributes to Incubation of Methamphetamine Craving.
Topics: Animals; Craving; Cues; Drug-Seeking Behavior; Excitatory Postsynaptic Potentials; Long-Term Synaptic Depression; Male; Methamphetamine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Metabotropic Glutamate; Spermine; Substance Withdrawal Syndrome | 2016 |
Increased self-reported impulsivity in methamphetamine users maintaining drug abstinence.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Depression; Female; Humans; Impulsive Behavior; Male; Methamphetamine; Self Report; Substance Withdrawal Syndrome; Young Adult | 2016 |
Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly.
Topics: Animals; Behavior, Addictive; Gene Knockdown Techniques; Glutamic Acid; Homer Scaffolding Proteins; Male; Methamphetamine; Mice; Mice, Inbred Strains; Microdialysis; Nucleus Accumbens; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Self Administration; Substance Withdrawal Syndrome | 2017 |
Effects of prolonged abstinence from METH on the hippocampal BDNF levels, neuronal numbers and apoptosis in methamphetamine-sensitized rats.
Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Cell Count; Central Nervous System Stimulants; Hippocampus; Male; Methamphetamine; Neurons; Rats, Wistar; Substance Withdrawal Syndrome | 2017 |
Withdrawal-like behavior in planarians is dependent on drug exposure duration.
Topics: Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Methamphetamine; Motor Activity; Planarians; Substance Withdrawal Syndrome; Time Factors | 2008 |
Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use.
Topics: Adaptation, Physiological; Adult; Amphetamine-Related Disorders; Brain; Drug Administration Schedule; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome | 2008 |
Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Agmatine; Animals; Benzoxazines; Cannabinoids; Methamphetamine; Morpholines; Motor Activity; Naphthalenes; Planarians; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 2008 |
"Ice" use and eating disorders: a report of three cases.
Topics: Adolescent; Central Nervous System Stimulants; Feeding and Eating Disorders; Feeding Behavior; Female; Hospitalization; Humans; Methamphetamine; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult | 2009 |
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
Topics: Adult; Analysis of Variance; Brain Mapping; Central Nervous System Stimulants; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substance Withdrawal Syndrome; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2008 |
Drug abstinence and cognitive control in methamphetamine-dependent individuals.
Topics: Adult; Amphetamine-Related Disorders; Attention; Cognition Disorders; Female; Humans; Male; Methamphetamine; Reaction Time; Substance Withdrawal Syndrome; Time Factors | 2009 |
Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.
Topics: Adult; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Electroencephalography; Female; Humans; Male; Memory; Memory Disorders; Methamphetamine; Neuropsychological Tests; Substance Withdrawal Syndrome; Theta Rhythm | 2009 |
Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
Topics: Adult; Amphetamine-Related Disorders; Australia; Data Collection; Female; Health Personnel; Humans; Male; Methamphetamine; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 2009 |
Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat.
Topics: Animals; Catheterization; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Frontal Lobe; Male; Methamphetamine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Self Administration; Serotonin; Substance Withdrawal Syndrome; Time Factors | 2010 |
White-matter abnormalities in brain during early abstinence from methamphetamine abuse.
Topics: Adult; Amphetamine-Related Disorders; Anisotropy; Brain; Case-Control Studies; Diffusion Magnetic Resonance Imaging; Female; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome; Young Adult | 2010 |
Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Substance Withdrawal Syndrome | 2010 |
First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians.
Topics: Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamic Acid; Hypnotics and Sedatives; Methamphetamine; Motor Activity; Muscarinic Antagonists; Planarians; Scopolamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 2010 |
Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi.
Topics: Animals; Calcium; Central Nervous System Stimulants; Endoplasmic Reticulum; Excitatory Amino Acid Agonists; Female; Hippocampus; Male; Methamphetamine; N-Methylaspartate; Neurons; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Substance Withdrawal Syndrome | 2010 |
5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Methamphetamine; Movement; Piperazines; Planarians; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2010 |
Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Central Nervous System Stimulants; Depressive Disorder; Female; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychotic Disorders; Recurrence; Substance Abuse Detection; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2010 |
[Methamphetamine dependence: Consequences and complications].
Topics: Amphetamine-Related Disorders; Cross-Cultural Comparison; Cross-Sectional Studies; France; Humans; Illicit Drugs; Methamphetamine; Risk Factors; Substance Withdrawal Syndrome | 2010 |
Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study.
Topics: Adult; Affect; Amphetamine-Related Disorders; Anxiety; Blood Pressure; Cognition; Female; Heart Rate; Humans; Male; Methamphetamine; Middle Aged; Pilot Projects; Prospective Studies; Sleep; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Time Factors | 2011 |
Mephedrone: use, subjective effects and health risks.
Topics: Adult; Alkaloids; Central Nervous System Stimulants; Cross-Sectional Studies; Dancing; Designer Drugs; Diagnostic and Statistical Manual of Mental Disorders; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; Music; Substance Abuse Detection; Substance Withdrawal Syndrome; Substance-Related Disorders; Telephone; United Kingdom | 2011 |
[Stimulative role of corticotropin-releasing factor in methamphetamine-seeking behavior induced by footshock].
Topics: Amygdala; Animals; Central Nervous System Stimulants; Conditioning, Operant; Corticotropin-Releasing Hormone; Drug-Seeking Behavior; Foot; Male; Methamphetamine; Physical Stimulation; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome | 2011 |
Mephedrone ("bath salt") pharmacology: insights from invertebrates.
Topics: Animals; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Data Interpretation, Statistical; Dopamine Antagonists; Environment; Illicit Drugs; Invertebrates; Methamphetamine; Planarians; Stereotyped Behavior; Substance Withdrawal Syndrome | 2012 |
Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brain; Caudate Nucleus; Central Nervous System Stimulants; Cerebral Cortex; Cross-Sectional Studies; Female; Globus Pallidus; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Neostriatum; Prefrontal Cortex; Smoking; Substance Withdrawal Syndrome; Young Adult | 2012 |
[JSNP Excellent Presentation Award for AsCNP 2011: improvement of cognitive impairments on withdrawal after repeated methamphetamine by administration of a cannabinoid CB1 receptor antagonist and a COX inhibitor].
Topics: Animals; Awards and Prizes; Cognition Disorders; Cyclooxygenase Inhibitors; Diclofenac; Male; Methamphetamine; Mice; Mice, Inbred ICR; Mice, Knockout; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome | 2012 |
Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry.
Topics: Adult; Aggression; Alleles; Amphetamine-Related Disorders; Amygdala; Brain; Brain Mapping; Central Nervous System Stimulants; Emotions; Facial Expression; Female; Frontal Lobe; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Introns; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Minisatellite Repeats; Nerve Net; Occipital Lobe; Pattern Recognition, Visual; Prefrontal Cortex; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2012 |
Chronic pre-exposure to methamphetamine following 31 days of withdrawal impairs sexual performance but not sexual conditioning in male Japanese quail.
Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Copulation; Coturnix; Male; Methamphetamine; Motivation; Motor Activity; Sexual Behavior, Animal; Substance Withdrawal Syndrome | 2012 |
A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats.
Topics: Animals; Compulsive Behavior; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Electric Stimulation; Emotions; Male; Methamphetamine; Rats; Rats, Wistar; Reward; Self Administration; Self Stimulation; Substance Withdrawal Syndrome; Time Factors | 2013 |
Acute withdrawal but not long-term withdrawal from methamphetamine affects sexual behavior in female rats.
Topics: Animals; Female; Male; Methamphetamine; Motor Activity; Rats; Rats, Long-Evans; Sex Characteristics; Sexual Behavior, Animal; Substance Withdrawal Syndrome; Time Factors | 2013 |
Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy.
Topics: Adult; Age Factors; Amphetamine-Related Disorders; Aspartic Acid; Choline; Creatine; Dopamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Neurons; Serotonin; Substance Withdrawal Syndrome; Visual Cortex | 2002 |
Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Female; Fluvoxamine; Humans; Methamphetamine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2003 |
[Studies on clinical features of nicotine dependence in comparison with those of alcohol and methamphetamine dependence using a two compartment model of drug dependence].
Topics: Adult; Alcoholism; Female; Humans; Male; Methamphetamine; Middle Aged; Social Problems; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 2003 |
Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Electroencephalography; Female; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome | 2003 |
REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
Topics: Alcoholism; Amobarbital; Amphetamine; Amphetamines; Barbiturates; Dextroamphetamine; Hospitals, Psychiatric; Humans; Methamphetamine; Narcotics; Paranoid Disorders; Phenmetrazine; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome; Substance-Related Disorders; Toxicology | 1964 |
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Arousal; Attention; Blood Glucose; Brain; Brain Mapping; Depression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Methamphetamine; Neuropsychological Tests; Reference Values; Substance Withdrawal Syndrome; Tomography, Emission-Computed | 2004 |
Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Temperature; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Hydrocortisone; Macaca mulatta; Male; Methamphetamine; Substance Withdrawal Syndrome | 2005 |
Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.
Topics: Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Circadian Rhythm; Cocaine; Cold Temperature; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Electrophysiology; Fever; Infusion Pumps, Implantable; Male; Methamphetamine; Motor Activity; Quinpirole; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Time Factors; Weight Gain | 2005 |
Relapse antecedents for methamphetamine use and related factors in Taiwanese adolescents.
Topics: Adolescent; Amphetamine-Related Disorders; Attitude to Health; Comorbidity; Female; Follow-Up Studies; Humans; Internal-External Control; Male; Mental Disorders; Methamphetamine; Personality Inventory; Prisons; Psychometrics; Recurrence; Retrospective Studies; Risk Factors; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Sympathomimetics; Taiwan | 2005 |
Epileptic seizure in GHB withdrawal.
Topics: Adult; Aggression; Dose-Response Relationship, Drug; Drug Administration Schedule; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Illicit Drugs; Male; Methamphetamine; Sodium Oxybate; Substance Withdrawal Syndrome; Violence | 2004 |
Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
Topics: Adult; Affect; Amphetamine-Related Disorders; Anticonvulsants; Antimanic Agents; Arousal; Bipolar Disorder; Central Nervous System Stimulants; Cocaine-Related Disorders; Comorbidity; Cross-Cultural Comparison; Depressive Disorder; Diagnosis, Differential; Diagnosis, Dual (Psychiatry); Female; Heroin Dependence; Humans; Language; Male; Methamphetamine; Middle Aged; Personality Inventory; Psychometrics; Reproducibility of Results; Substance Withdrawal Syndrome; Substance-Related Disorders; Temperament; Treatment Outcome | 2005 |
Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Topics: Adult; Ambulatory Care; Amphetamine-Related Disorders; Aspartic Acid; Brain; Choline; Creatine; Dopamine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Phosphocreatine; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Tissue Distribution; Visual Cortex | 2005 |
Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Topics: Amphetamine-Related Disorders; Animals; Arousal; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hippocampus; Male; Methamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Stress, Psychological; Substance Withdrawal Syndrome | 2005 |
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers.
Topics: Adult; Arousal; Atrophy; Brain; Brain Mapping; Central Nervous System Stimulants; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methamphetamine; Neuropsychological Tests; Positron-Emission Tomography; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
The nature, time course and severity of methamphetamine withdrawal.
Topics: Acute Disease; Adolescent; Adult; Central Nervous System Stimulants; Cross-Sectional Studies; Depression; Female; Humans; Male; Methamphetamine; Psychometrics; Sleep; Substance Withdrawal Syndrome | 2005 |
Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.
Topics: Adult; Aggression; Amphetamine-Related Disorders; Brain; Brain Mapping; Carbon Radioisotopes; Case-Control Studies; Female; Humans; Isoquinolines; Male; Methamphetamine; Neurons; Positron-Emission Tomography; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome; Tissue Distribution | 2006 |
Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.
Topics: Animals; Blotting, Western; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Image Processing, Computer-Assisted; In Situ Hybridization; Limbic System; Male; Methamphetamine; Neostriatum; Rats; Rats, Long-Evans; RNA, Messenger; Self Administration; Substance Withdrawal Syndrome; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2006 |
Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat.
Topics: Acetylcarnitine; Animals; Antidepressive Agents; Conditioning, Operant; Dopamine Agonists; Indoles; Lisuride; Male; Methamphetamine; Motivation; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sweetening Agents | 2006 |
Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.
Topics: Amphetamine-Related Disorders; Amphetamines; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cognition Disorders; Dextroamphetamine; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Perceptual Disorders; Psychomotor Performance; Rats; Reaction Time; Substance Withdrawal Syndrome; Time; Visual Perception | 2007 |
Alterations in blood-brain barrier function by morphine and methamphetamine.
Topics: Analgesia; Animals; Blood-Brain Barrier; Fever; HSP72 Heat-Shock Proteins; Methamphetamine; Mice; Morphine; Morphine Dependence; Neuroglia; Neurons; Neuropil; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2006 |
L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
Topics: Animals; Behavior, Animal; Body Weight; Central Nervous System Stimulants; Clorgyline; Conditioning, Operant; Extinction, Psychological; Indans; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Morphine; Morphine Dependence; Rats; Rats, Wistar; Reinforcement, Psychology; Selegiline; Self Administration; Substance Withdrawal Syndrome | 2006 |
Craving and control: methamphetamine users' narratives.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cues; Data Collection; Data Interpretation, Statistical; Female; Humans; Male; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome | 2006 |
Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal.
Topics: Animals; Drug Therapy, Combination; Male; Methamphetamine; Ondansetron; Pergolide; Rats; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome | 2007 |
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse.
Topics: Acoustic Stimulation; Adult; Attention; Brain Mapping; Case-Control Studies; Cerebral Cortex; Depression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methamphetamine; Positron-Emission Tomography; Reaction Time; Substance Withdrawal Syndrome; Task Performance and Analysis | 2008 |
The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.
Topics: Amphetamine-Related Disorders; Animals; Binding, Competitive; Calcineurin; Cyclic AMP; Cyclohexanols; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Male; Methamphetamine; Nucleus Accumbens; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; RNA, Messenger; Signal Transduction; Substance Withdrawal Syndrome | 2007 |
Potentiation of N-methyl-D-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors.
Topics: Animals; Animals, Newborn; Cell Death; Cell Survival; Central Nervous System Stimulants; Drug Interactions; Drug Synergism; Excitatory Amino Acid Antagonists; Female; Hippocampus; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Male; Methamphetamine; Nerve Degeneration; Organ Culture Techniques; Oxazoles; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2008 |
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anti-Bacterial Agents; Ceftriaxone; Clorazepate Dipotassium; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Methamphetamine; Models, Animal; Motor Activity; Planarians; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2008 |
Immune to the high.
Topics: Humans; Methamphetamine; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Vaccines | 2008 |
Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.
Topics: Aminoquinolines; Animals; Benzamides; Central Nervous System Stimulants; In Vitro Techniques; Methamphetamine; Motor Activity; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Opioid Peptides; Planarians; Receptors, Opioid; Substance Withdrawal Syndrome | 2008 |
The search for medications to treat stimulant dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Brain; Bupropion; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Drug Approval; Humans; Methamphetamine; Modafinil; Propranolol; Psychotropic Drugs; Secondary Prevention; Substance Withdrawal Syndrome; Token Economy | 2008 |
Response: anticipating new medications.
Topics: Amphetamine-Related Disorders; Cocaine; Cocaine-Related Disorders; Humans; Methamphetamine; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Psychotropic Drugs; Secondary Prevention; Substance Withdrawal Syndrome | 2008 |
CNS stimulants and the look-alike drugs.
Topics: Amphetamine; Caffeine; Central Nervous System Stimulants; Depressive Disorder; Ephedrine; Humans; Illicit Drugs; Methamphetamine; Phenylpropanolamine; Stimulation, Chemical; Substance Withdrawal Syndrome; Substance-Related Disorders; United States; United States Food and Drug Administration | 1984 |
Formation of physical dependence on barbiturates and cerebral monoamines.
Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Biogenic Amines; Body Weight; Brain; Catecholamines; Fenclonine; Humans; Hydroxyindoleacetic Acid; Male; Methamphetamine; Methyltyrosines; Rats; Rats, Inbred Strains; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine; Tyrosine 3-Monooxygenase | 1983 |
[Studies on the reverse tolerance phenomenon after repeated methamphetamine treatment in rats].
Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Injections, Intraperitoneal; Male; Methamphetamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substance Withdrawal Syndrome | 1984 |
Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
Topics: Adult; Delusions; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Paranoid Disorders; Psychoses, Substance-Induced; Recurrence; Schizophrenia, Paranoid; Schizophrenic Psychology; Substance Withdrawal Syndrome; Triflupromazine | 1983 |
Amphetamine use.
Topics: Aged; Depressive Disorder; Female; Humans; Methamphetamine; Substance Withdrawal Syndrome | 1983 |
[Neuropharmacological studies on drug dependence (II). Changes in spontaneous motor activity, EEG and brain monoamines during the period of dependence development and of abrupt withdrawal in rats, with special reference to circadian rhythm (author's trans
Topics: Animals; Biogenic Amines; Brain; Circadian Rhythm; Cocaine; Diazepam; Electroencephalography; Humans; Male; Methamphetamine; Morphine Dependence; Motor Activity; Opioid-Related Disorders; Phenobarbital; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1980 |
Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
Topics: Animals; Behavior, Animal; Drug Interactions; Haloperidol; Humans; Male; Methamphetamine; Motor Activity; Rats; Substance Withdrawal Syndrome; Sulpiride | 1981 |
Cardiac lesions and their reversibility after long term administration of methamphetamine.
Topics: Animals; Heart; Heart Diseases; Male; Methamphetamine; Microscopy, Electron; Myocardium; Prospective Studies; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sympathomimetics; Time Factors | 1995 |
Effects of daily administration of methamphetamine on multiple active/passive avoidance performance in rats.
Topics: Animals; Avoidance Learning; Brain Chemistry; Conditioning, Operant; Electroshock; Male; Methamphetamine; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Substance Withdrawal Syndrome | 1993 |
Changes in monoamine oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal.
Topics: Animals; Brain; Methamphetamine; Mice; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain.
Topics: Animals; Brain Chemistry; Cholecystokinin; Dopamine Uptake Inhibitors; In Situ Hybridization; Male; Methamphetamine; Oligonucleotide Probes; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance Withdrawal Syndrome; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 1996 |
Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; California; Central Nervous System Stimulants; Comorbidity; Depression; Female; Humans; Male; Mental Disorders; Methamphetamine; Middle Aged; Population Surveillance; Prisons; Substance Withdrawal Syndrome; Suicide; Surveys and Questionnaires | 2000 |
Nicotine, alcohol, methamphetamine, and inhalant dependence: a comparison of clinical features with the use of a new clinical evaluation form.
Topics: Administration, Inhalation; Adult; Alcoholism; Humans; Interpersonal Relations; Mental Disorders; Methamphetamine; Methods; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 2001 |
Lack of persistent changes in the dopaminergic system of rats withdrawn from methamphetamine self-administration.
Topics: Animals; Immunohistochemistry; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Self Administration; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2002 |
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.
Topics: Adult; Brain; Contrast Media; Diagnosis, Computer-Assisted; Echo-Planar Imaging; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Male; Methamphetamine; Neuropsychological Tests; Organometallic Compounds; Reaction Time; Reference Values; Regional Blood Flow; Substance Withdrawal Syndrome; Substance-Related Disorders | 2002 |
Proceedings: Methylamphetamine withdrawal as a model for the depressive state: antagonism of post-amphetamine depression by imipramine.
Topics: Animals; Brain Chemistry; Depression; Disease Models, Animal; Humans; Imipramine; Male; Methamphetamine; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1975 |
[Drug dependence test on a cerebral insufficiency improver, aniracetam].
Topics: Animals; Brain; Cocaine; Drug Evaluation, Preclinical; Macaca fascicularis; Male; Memory; Methamphetamine; Pentobarbital; Pyrrolidinones; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders | 1987 |
Similarities in feeding behavior of chronic methamphetamine treated and withdrawn rats to VMH lesioned rats.
Topics: Animals; Body Weight; Circadian Rhythm; Drinking Behavior; Feeding Behavior; Food Preferences; Glucose; Male; Methamphetamine; Models, Psychological; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Ventromedial Hypothalamic Nucleus | 1985 |
Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion.
Topics: Adult; Affect; Amphetamine; Brain; Catechols; Depression; Electroencephalography; Female; Glycols; Humans; Male; Methamphetamine; Norepinephrine; Psychological Tests; Sleep; Sleep, REM; Substance Withdrawal Syndrome; Substance-Related Disorders | 1972 |
Significance of withdrawal jumping response in predicting physical dependence in mice.
Topics: Amitriptyline; Animals; Atropine; Cannabis; Chlordiazepoxide; Chlorpromazine; Diazepam; Humans; Imipramine; Male; Mephenesin; Methamphetamine; Mice; Morphine Dependence; Naloxone; Pentobarbital; Perphenazine; Phenytoin; Reserpine; Substance Withdrawal Syndrome | 1973 |
Changes in cerebral carbohydrate metabolism in the rat after acute and chronic treatment with, and withdrawal of, methamphetamine.
Topics: Administration, Oral; Animals; Brain; Carbohydrate Metabolism; Carbon Radioisotopes; Female; Glucose; Glutamates; Glycogen; Humans; Injections, Intraperitoneal; Lactates; Male; Methamphetamine; Rats; Substance Withdrawal Syndrome; Time Factors | 1974 |
An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury.
Topics: Anxiety; Drug Tolerance; Fatigue; Gastrointestinal Diseases; Hepatitis; Humans; Injections, Intravenous; Methamphetamine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Substance-Related Disorders | 1970 |